World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
73
Citations
38229
World Ranking
19527
National Ranking
789

Overview

Alessandro Testori is affiliated with Fondazione Politecnico di Milano in Italy and has contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research primarily focuses on oncology, with a significant emphasis on melanoma and related molecular pathways.

Their work spans several subfields including oncology, molecular biology, epidemiology, immunology, and biophysics. Key topics in their research include cutaneous melanoma detection and management, melanoma and MAPK pathways, CAR-T cell therapy research, cancer immunotherapy and biomarkers, nonmelanoma skin cancer studies, immunotherapy and immune responses, and cell image analysis techniques.

They have published frequently in the following venues:

  • Annals of Oncology
  • Annals of Surgical Oncology
  • European Journal of Cancer
  • Journal of Translational Medicine
  • Journal of Clinical Oncology

Major recent publications by Alessandro Testori include:

  • ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee, 2020, Annals of Oncology
  • ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee, 2020, Annals of Oncology
  • Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts, 2020, Journal of Clinical Oncology
  • Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC), 2022, Annals of Surgical Oncology
  • Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma, 2022, JAMA Surgery

Frequent collaborators include Alexander C.J. van Akkooi, Paolo A. Ascierto, Corrado Caracò, Mark B. Faries, and Christian U. Blank.

Best Publications

  • Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

    Paul B. Chapman;Axel Hauschild;Caroline Robert;John B. Haanen

  • Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

    Caroline Robert;Luc Thomas;Igor Bondarenko;Steven O'Day

  • Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

    Alexander M M Eggermont;Vanna Chiarion-Sileni;Jean-Jacques Grob;Reinhard Dummer

  • Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

    Mark B. Faries;John F. Thompson;Alistair J. Cochran;Robert H. Andtbacka

  • Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial

    Alexander M M Eggermont;Vanna Chiarion-Sileni;Jean Jacques Grob;Reinhard Dummer

  • Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

    Grant A McArthur;Paul B Chapman;Caroline Robert;James Larkin

  • The role of BRAF V600 mutation in melanoma

    Paolo A. Ascierto;John M. Kirkwood;Jean Jacques Grob;Ester Simeone

  • Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.

    Alexander M. M. Eggermont;Stefan Suciu;Mario Santinami;Alessandro Testori

  • Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial

    Michele Maio;Jean Jacques Grob;Steinar Aamdal;Igor Bondarenko

  • Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

    Filiberto Belli;Alessandro Testori;Licia Rivoltini;Michele Maio

  • Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

    Alexander Stratigos;Claus Garbe;Celeste Lebbe;Josep Malvehy

  • Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline

    Celeste Lebbe;Jürgen C Becker;Jean-Jacques Grob;Josep Malvehy

  • Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial.

    Alexander M. M. Eggermont;Stefan Suciu;Rona Mackie;Wlodzimierz Ruka

  • Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study

    Richard K Burt;Yvonne Loh;Bruce Cohen;Dusan Stefosky

  • Prognostic significance of HER-2/NEU expression in breast cancer and its relationship to other prognostic factors

    F Rilke;M I Colnaghi;N Cascinelli;S Andreola

  • Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group

    Alessandro Testori;Jon Richards;Eric Whitman;G. Bruce Mann

  • Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma

    Alexander M.M. Eggermont;Stefan Suciu;Alessandro Testori;Mario Santinami

  • Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

    Anna Maria Di Giacomo;Paolo A. Ascierto;Lorenzo Pilla;Mario Santinami

  • Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma

    Steven J. O'Day;Alexander M.M. Eggermont;Vanna Chiarion-Sileni;Richard Kefford

  • Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma

    Wim H J Kruit;Stefan Suciu;Brigitte Dreno;Laurent Mortier

Frequent Co-Authors

Judith Campisi
Judith Campisi Buck Institute for Research on Aging
Norman Latov
Norman Latov Cornell University
Sandro Sorbi
Sandro Sorbi University of Florence
Martin Stangel
Martin Stangel Hannover Medical School
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Giuseppe Lauria
Giuseppe Lauria University of Milan
David Yarnitsky
David Yarnitsky Technion – Israel Institute of Technology
Takanori Yokota
Takanori Yokota Institute of Science Tokyo
Claudia Sommer
Claudia Sommer University of Würzburg
David R. Cornblath
David R. Cornblath Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring an education in Medicine isn’t limited to becoming a physician; there are many flexible, rewarding online pathways. For those interested in healthcare administration, medical billing and coding online programs teach in-demand skills for managing patient records and insurance claims. These courses can often be completed quickly and open the door to entry-level roles in medical settings.

If you’re considering direct patient care, there are several affordable online nursing programs to help you become an RN or advance within nursing. For those aiming to take on greater responsibility and autonomy, some cheap np programs offer a path to becoming a nurse practitioner—a high-demand, leadership position in healthcare.

Ambitious professionals may also pursue advanced research and academic roles. Earning a doctorate through phd nursing programs can lead to opportunities in university teaching, research, and executive leadership.

Ultimately, the growth of online education offers many affordable ways to start or advance a career in healthcare, even outside traditional medical degrees.

Best Scientists Citing Alessandro Testori

Trending Scientists